Perrigo Company PRGO

$14.26 +0.24 (1.71%)

Valuation

Market cap
1,945,541,000
Revenue TTM
$4,253,100,000
Net income TTM
$-1,425,400,000
PE ratio
5.90
Forward PE
6.76
Profit margin
-33.51%
Debt to equity
1.31

Trading

Volume
2,168,900
Avg volume
2,863,026
Day's range
$14.12 – $14.80
Shares out
138,769,000
Stochastic %K
26%
Beta
0.69
Analysts
Sell
Price target
$15.25

Price

Company profile

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverag...

Show more

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Phone
353 1 709 4000
Website
https://www.perrigo.com
Address
The Sharp Building, Hogan Place, Dublin, Ireland

Latest news

No headlines yet.

Stocktwits

QuietTrader Oct 2, 2:15 PM
Stocks to watch today: $PRGO (I did a write-up on this yesterday: https://stocktwits.com/QuietTrader/message/665575105) $BSX - Currently strongly bouncing off the year lows: might be worth a trade $CIFR $MXL
0 replies
QuietTrader Oct 1, 8:30 PM
$PRGO - I've been patiently waiting for this opportunity. Started a position with 4000 shares at 14.05. Let's me tell you why I've been hunting this stock down... 1) Golden Cross ✅ 2) Higher lows ✅ 3) Healthcare seasonality ✅ 4) 16%+ short float ✅ 5) Huge overhead recovery potential ✅ PRGO just printed the technical signal bulls have been waiting for: the 50-day MA crossed above the 200-day MA — a Golden Cross. PRGO has a history of violent repricing once long-term momentum turns. This is a stock that spent years making major multi-month and multi-year runs when the trend became established. The current setup is coming after a brutal washout to ~$9, followed by higher lows, improving momentum and a major trend reversal. And PRGO has already shown us what happens when buyers step in: +6.1% on Sept. 24 on 7.7M shares, followed by another +5.0% the next day. That’s not sleepy price action. When this stock gets going, it can MOVE. MarketWatch Now add the gasoline: 16.4% of the float is short with ~9.3 days to cover. If PRGO clears the recent resistance zone and momentum traders arrive, shorts could become forced buyers. MarketBeat The upside roadmap is obvious: $15.50 → $17 → $18.50 → $20+ And remember: PRGO was trading above $22 only a year ago. At ~$14, there is a huge amount of overhead territory that could be reclaimed if this turnaround sticks. MarketWatch The macro seasonal backdrop is also lining up. Q4 of midterm-election years has historically been one of the strongest market windows — the S&P 500 has averaged about +6.6% and finished positive in 16 of the last 19 midterm Q4s since 1950. MarketWatch Healthcare specifically has shown an impressive late-midterm tendency as well: XLV rose in 5 of the last 6 Sep. 3–Nov. 6 midterm windows, averaging about +5% across all six observations. Healthcare is also currently among the stronger sectors on a relative-strength basis. I think the market is badly underestimating how fast $PRGO could reprice if $15–$15.50 breaks. This one won’t need everyone to become bullish. It just needs the trend to force them to chase.
1 replies
Jleon1793 Oct 1, 7:52 PM
$PRGO Healthy movement. Hoping this can touch mid 12s before next earnings for a chance to swing trade some shares
0 replies
TheWoodpacker Sep 26, 9:55 AM
$PRGO Some very bullish signals: 1.) Golden Cross SMA50/200 on the daily 2.) Close above strong resistance at around $15.25 - now possible support. First couple of hours after the breach indicate so. 3.) inversive head and shoulder pattern 4.) high volume traffic 5.) Global extrinsic economic factors did not effect the rally. (note - this is the best case...if Q3 earnings is a beat like the prior two Qs I am positive).
1 replies
Avocado_smash Sep 26, 7:05 AM 1 replies
WillRobinson Sep 26, 2:18 AM
$PRGO stoopid point - if today were November 5, 2026 we would have achieved a NEW 52 week high Just sayin
0 replies
QuantInsider Sep 25, 10:25 PM
$PRGO up about 5% today, making it around 15% over five days Big moves with no fresh news Seeing about 3,000 aggressive 10/16 $15 call sweeps hitting the ask on InsiderFinance That's some serious bullish momentum into mid-October as long as it holds above that strike Also spotted a 500-contract sweep on the 10/16 $17.50 calls Could be a defined-risk bet on further upside Watch that $17.50 level as a stretch target Heads up, elevated IVs mean higher risk if this momentum stalls Keep an eye on it
1 replies
TalkMarkets Sep 25, 8:26 PM
Textbook Monthly Accumulation After A Decade-Long Decline $PRGO Also Mentions: $WMT $AMZN $COST https://talkmarkets.com/article/textbook-monthly-accumulation-after-a-decade-long-decline
0 replies